On May 3, 2022, Baxter International Inc. ("the Company") appointed each of D. Brent Shafer and Peter M. Wilver to its Board of Directors ("the Board"), with such appointments to become effective on May 10, 2022. Upon
their appointment to the Board on May 10, 2022, the number of directors constituting the Board will increase to thirteen directors. Upon their appointment to the Board, Mr. Shafer will be appointed to serve on the Audit
Committee and Compensation Committee and Mr. Wilver will be appointed to serve on the Compensation Committee. Mr. Shafer, 64, previously served as the Chairman of the Board and Chief Executive Officer of Cerner
Corporation from 2018 to 2021. Mr. Wilver, 62, previously served as the Executive Vice President and Chief Administrative Officer of Thermo Fisher Scientific Inc. from 2015 until his retirement in 2017. On May 4, 2022, Peter S. Hellman notified the Company of his decision to retire from the Board, effective as of June 30, 2022. Following Mr. Hellman's retirement on June 30, 2022, the number of directors constituting the Board will decrease to twelve directors.